Opus Genetics, Inc. Recorded Big Gain
Wed, Sep 09, 2026 at 07:36 PM
Opus Genetics, Inc. (IRD:NASDAQ) soared at $5.73, representing a gain of 32%. On Wed, Sep 09, 2026, IRD:NASDAQ hit a New 2-Week High of $5.73. The stock got featured on our News Catalysts scanner on Wed, Sep 09, 2026 at 01:44 PM in the 'BIOTECH' category. From Wed, Aug 26, 2026, the stock recorded 66.67% Up Days and 50.00% Green Days
About Opus Genetics, Inc. (IRD:NASDAQ)
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.
Top 10 Gainers:
- Megan Holdings Limited (MGN:NASDAQ), 174.7%
- SUNation Energy Inc. (SUNE:NASDAQ), 90.3%
- J-Star Holding Co. Ltd. (YMAT:NASDAQ), 71.32%
- Future FinTech Group Inc. (FTFT:NASDAQ), 59.54%
- Lafayette Digital Acquisition Corp. I (ZKPW:NASDAQ), 34.96%
- Opus Genetics, Inc. (IRD:NASDAQ), 32.03%
- Oddity Tech Ltd. (ODD:NASDAQ), 26.53%
- Ribbon Acquisition Corp. (RIBB:NASDAQ), 25.71%
- Gelteq Limited (GELS:NASDAQ), 25.66%
- Uni-Fuels Holdings Limited (UFG:NASDAQ), 24.97%